← Back to catalogue
Published

haloxazolam

vr.tr.haloxazolam · thing-q4345875

Enable an agent to recognise haloxazolam, assess the identity and fitness of its material samples, and determine which handling or use decisions require further evidence.

Thing Registry Physical world and living systems PHY.MAT

Bundle → Layer → Finding → Questions Filled

6 bundles · 11 layers · 16 findings · 26 questions

Haloxazolam identity Establish the chemical entity behind the registry name.

Structure and identifiers

Reconcile the registered name with an authoritative molecular identity.

Identifier and structure agreement

Require identifiers to resolve to the same haloxazolam structure rather than relying on name similarity.

  1. Which authoritative records connect haloxazolam, CAS 59128-97-1 and PubChem CID 3563 to the same molecular structure? provenance
  2. Which structural checks distinguish this sample from oxazolam and other similarly named benzodiazepines? definition

Stereochemistry and entity boundaries

Define correspondence between the registered substance and particular material representations.

Stereochemical material match

Record whether a material matches the referenced stereochemical specification and whether it is neat substance or a mixture.

  1. What stereochemical composition does the applicable haloxazolam specification require, and what evidence establishes the sample's composition? measurement
  2. Is the record for haloxazolam itself, an isolated stereoisomer, a reference solution or a finished medicine? boundary
Haloxazolam quality Determine whether a material is sufficiently characterised for its intended use.

Assay and grade

Connect measured content to a declared specification.

Content and conformity

Keep assay basis, analytical specificity and specification compliance explicit.

  1. What haloxazolam content was measured, on what mass basis, and does the method distinguish relevant related substances? measurement
  2. Which specification edition and batch-specific certificate support the claimed grade? provenance

Impurities and reference traceability

Assess related substances, residual materials and the standards used to measure them.

Impurity evidence

Document quantified impurities and analytical blind spots rather than treating an assay value as complete purity evidence.

  1. Which haloxazolam-related impurities, residual solvents and water content were tested, and with what reporting limits? measurement
  2. Which authenticated reference standards establish identity and quantitative traceability for this batch? provenance
Haloxazolam material state Represent the conditions under which physical-property and stability observations apply.

Solid form and thermal properties

Characterise the solid without assuming all haloxazolam samples behave identically.

Physical form evidence

Connect appearance, crystallinity and thermal transitions to a characterised sample.

  1. What observations establish the sample's phase and solid form, and is any polymorph or solvate assignment supported? measurement
  2. What melting range or decomposition behaviour is experimentally supported, using which method and sample purity? measurement

Solution and storage behaviour

Determine when prepared solutions and stored material remain suitable.

Preparation and stability window

Require evidence for solvent choice, achievable concentration and retention of chemical identity.

  1. What haloxazolam solubility is measured in the proposed solvent at the relevant temperature and pH? measurement
  2. What stability evidence supports storage or use of the bulk substance and prepared solution after light, moisture or temperature exposure? action
Haloxazolam biological behaviour Connect substance identity with pharmacological evidence while retaining experimental context.

Activity and effect evidence

Separate target-level observations from therapeutic product claims.

Pharmacological attribution

Attribute receptor activity and hypnotic effects to the tested entity and evidence type.

  1. Which experiments establish haloxazolam's receptor interactions, and what species, assay and concentrations were used? provenance
  2. Which reported effects concern the parent substance, its metabolites or an administered medicinal product? boundary

Metabolism and persistence

Represent transformation and exposure duration without collapsing distinct analytes.

Parent and metabolite discrimination

Attach metabolic and pharmacokinetic observations to an identified analyte and study population.

  1. Which haloxazolam metabolites have been experimentally identified, and which have demonstrated pharmacological activity? provenance
  2. For each reported half-life or exposure value, which analyte, biological matrix, population and dosing conditions were measured? measurement
Haloxazolam handling and controls Connect substance-specific hazards and legal identity to proposed actions.

Hazard and exposure evidence

Distinguish documented pharmacological risks from bulk-material handling classifications.

Risk context separation

The cited product label identifies next-day impairment, dependence and respiratory depression; bulk-material exposure controls require their own evidence. [PMDA product label](https://www.pmda.go.jp/PmdaSearch/iyakuDetail/ResultDataSetPDF/530258_1124005C1032_2_05)

  1. Which current substance-specific safety data support GHS classification and occupational exposure controls for the material being handled? provenance
  2. What controls are justified for weighing powder or handling solutions, and which exposure limits remain unestablished? action

Jurisdiction and use permissions

Resolve legal requirements for the substance and the proposed activity.

Dated regulatory determination

Record dated authority for possession, transfer, import and use without treating a product label as universal legal permission.

  1. Which current legal instruments identify haloxazolam and establish applicable controls in the origin and destination jurisdictions? provenance
  2. What authorisations and records are required for the proposed research, supply, import or disposal activity? action
Evidence and external alignment What the world already says about this thing, gathered so the model can be checked against it.

Reported evidence

Findings from the breadth pass, kept separate from the structural claims.

Check these first

Recalled without web access and unsourced; every item is a lead to verify.

  1. Which of these check these first hold for the sense of haloxazolam this model covers, and on what evidence? provenance

Identifiers and schemes

Recalled without web access and unsourced; every item is a lead to verify.

  1. Which of these identifiers and schemes hold for the sense of haloxazolam this model covers, and on what evidence? provenance

Real-world use

Recalled without web access and unsourced; every item is a lead to verify.

  1. Which of these real-world use hold for the sense of haloxazolam this model covers, and on what evidence? provenance

Failure modes and hazards

Recalled without web access and unsourced; every item is a lead to verify.

  1. Which of these failure modes and hazards hold for the sense of haloxazolam this model covers, and on what evidence? provenance

Regional variation

Recalled without web access and unsourced; every item is a lead to verify.

  1. Which of these regional variation hold for the sense of haloxazolam this model covers, and on what evidence? provenance

Neighbouring kinds and how to tell them apart

Recalled without web access and unsourced; every item is a lead to verify.

  1. Which of these neighbouring kinds and how to tell them apart hold for the sense of haloxazolam this model covers, and on what evidence? provenance

Classifiers Filled

Family
Thing Registry
Category
Physical world and living systems
Entry kind
thing
Plane
PHY
Domain
PHY.MAT

What it is Filled

Haloxazolam is an oxazolobenzodiazepine drug with sedative and hypnotic activity that has been used to treat insomnia.

In scope

  • Molecular identity, identifiers and stereochemical specification
  • Bulk substance and reference-material composition, purity and grade
  • Physical properties, stability and storage conditions
  • Substance-level pharmacology and relationships to metabolites
  • Hazard evidence and legal conditions affecting possession, transfer and use

Out of scope

  • Somelin and other finished medicinal products, their excipients and packaging
  • Individual prescribing, dosing, withdrawal management and patient care
  • Insomnia as a condition and its treatment pathway
  • Manufacturing routes and production equipment
  • Independent models of metabolites and other benzodiazepines

Why it exists Filled

Enable an agent to recognise haloxazolam, assess the identity and fitness of its material samples, and determine which handling or use decisions require further evidence.

Distinguishing features Filled

  • Match the molecular structure and identifiers together: haloxazolam has formula C17H14BrFN2O2, CAS 59128-97-1 and PubChem CID 3563; a similar name alone is insufficient. [PubChem](https://pubchem.ncbi.nlm.nih.gov/compound/Haloxazolam)
  • Confirm the brominated, fluorophenyl-substituted fused oxazolo-benzodiazepinone structure rather than accepting any benzodiazepine or a formula-only match. [Japanese Pharmacopoeia XVIII](https://www.mhlw.go.jp/content/11120000/000904440.pdf)
  • Check stereochemical correspondence to the pharmacopoeial designation (11bRS); an isolated stereoisomer must not silently inherit the same material specification. [Japanese Pharmacopoeia XVIII](https://www.mhlw.go.jp/content/11120000/000904440.pdf)
  • Distinguish the active substance from a medicine containing it: the cited Somelin label describes tablets and fine granules with haloxazolam plus excipients. [PMDA product label](https://www.pmda.go.jp/PmdaSearch/iyakuDetail/ResultDataSetPDF/530258_1124005C1032_2_05)

What robots and AI may and may not do Filled

Must not

  • Recommend, dose or supply it to a person without a prescriber's decision.
  • Assist in giving it to anyone without their knowledge.
  • Advise combining it with alcohol, opioids or other sedatives.
  • Help obtain it outside lawful supply channels.

Only with a human decision

  • Any decision to start, stop or taper treatment.

May

  • Describe haloxazolam's class, sedative effects and use for insomnia where licensed.
  • Explain dependence and withdrawal risks of benzodiazepines in general terms.

Moral aspects Filled

  • Sedatives can be misused to incapacitate people; covert dosing is a serious crime.
  • Long-term use causes dependence that patients must be warned about.

Who is affected

  • Patients with insomnia
  • Older people at risk of falls
  • Potential victims of covert dosing

Owners Filled

Steward

The marketing authorisation holder where it is licensed; the prescriber answers for each use.

Master systems

  • National medicines registers
  • National controlled substance schedules

Links to other meta-models Filled

parent

  • Q11173 - registry parent class

What else AI and robots need to interact with it Filled

Identity and identifiers required Filled

  • Vercy registry: vr.tr.haloxazolam
  • Wikidata: Q4345875 (https://www.wikidata.org/wiki/Q4345875)

Direct properties required Filled

  • Molecular identity: Structure representation, stereochemical designation, CAS and PubChem identifiers
  • Assay and reporting basis: % mass fraction; as-is or dried basis; method and uncertainty
  • Impurity profile: Individual and total impurities in % or mg/kg; detection and quantification limits
  • Material grade: Pharmacopoeial substance, analytical reference material, research material or unverified; specification edition
  • Physical form: Observed phase, crystallinity, solid-form assignment and measurement conditions
  • Thermal behaviour: Melting range or decomposition onset in °C; method; pressure where relevant
  • Solubility: mg/mL or mol/L with solvent, temperature, pH and equilibration method
  • Stability status: Within supported storage conditions, excursion pending assessment, degraded or unknown
  • Pharmacological and metabolic relationships: Target, effect and metabolite links with species, assay and evidence source
  • Hazard and regulatory applicability: GHS classification, exposure-limit status and controlled-substance status, each with jurisdiction, source and date

Recognition required Filled

  • Identity cannot be settled by sight; tablets must be confirmed by label and pharmacy records.

Capabilities and actions required Filled

  • Resolve a named substance or sample against haloxazolam identifiers and structural evidence.
  • Compare a batch certificate and analytical results with its declared grade.
  • Assess whether a proposed analytical solvent and storage condition have supporting evidence.
  • Link haloxazolam to containing products and reported metabolites without merging their identities.
  • Flag unsupported handling or transfer decisions for chemical-safety or regulatory review.

Hazards and failure modes required Filled

  • Dependence, withdrawal and rebound insomnia.
  • Drowsiness, falls and impaired driving.
  • Dangerous breathing suppression when combined with other sedatives.

Standards and interfaces required Filled

  • Convention on Psychotropic Substances 1971, Schedule IV, United Nations.

Context of use required Filled

  • Haloxazolam is encountered in pharmaceutical contexts as a sedative and hypnotic compound that has been used to treat insomnia.
  • It is also encountered in analytical and pharmacological research concerning compound identity, drug action and metabolism.

Sources Filled

  1. Wikidata item Q4345875: haloxazolam - identity and sense of the item
  2. Wikipedia: Haloxazolam - general description of the item

Open questions

  • Which current pharmacopoeial edition governs haloxazolam identity, assay, stereochemical specification and impurity acceptance criteria?
  • Which solid forms, melting or decomposition measurements and quantitative solubility values have reliable experimental support, and is a boiling-point value physically meaningful?
  • Which metabolites and human pharmacokinetic measurements establish the respective contributions of parent substance and metabolites to persistence?
  • What current bulk-substance SDS, GHS classifications, occupational exposure limits and EC identifier, if any, can be verified?
  • Which storage conditions, retest periods and jurisdiction-specific legal permissions are supported for the particular grade and intended activity?

Machine files

Provenance

thing registry research (pass 2) · unreviewed

Built from: models/things/publications/thing-q4345875/spec.json